Modulation of Lymphocyte Function for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

被引：0
|
作者：
Ralph, Christy [1 ,2 ]
Elkord, Eyad [1 ]
Thistlethwaite, Fiona C. [1 ]
Burt, Debbie J. [1 ]
O'Dwyer, Jackie [1 ]
Stern, Peter L. [2 ]
Hawkins, Robert F.
机构：
[1] Christie NHS Fdn Trust, Paterson Inst Canc Res, Manchester, Lancs, England
[2] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England
来源：
JOURNAL OF IMMUNOTHERAPY | 2009年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：960 / 961
页数：2
相关论文
共 50 条
  • [21] Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer
    Ilson, DH
    Saltz, L
    Enzinger, P
    Huang, Y
    Kornblith, A
    Gollub, M
    O'Reilly, E
    Schwartz, G
    DeGroff, J
    Gonzalez, G
    Kelsen, DP
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3270 - 3275
  • [22] Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer
    Burtness, B.
    Gibson, M.
    Egleston, B.
    Mehra, R.
    Thomas, L.
    Sipples, R.
    Quintanilla, M.
    Lacy, J.
    Watkins, S.
    Murren, J. R.
    Forastiere, A. A.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1242 - 1248
  • [23] Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
    Yoon, H. H.
    Bendell, J. C.
    Braiteh, F. S.
    Firdaus, I.
    Philip, P. A.
    Cohn, A. L.
    Lewis, N.
    Anderson, D. M.
    Arrowsmith, E.
    Schwartz, J. D.
    Gao, L.
    Hsu, Y.
    Xu, Y.
    Ferry, D.
    Alberts, S. R.
    Wainberg, Z. A.
    ANNALS OF ONCOLOGY, 2016, 27 (12) : 2196 - 2203
  • [24] Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
    Pera, M.
    Gallego, R.
    Montagut, C.
    Martin-Richard, M.
    Iglesias, M.
    Conill, C.
    Reig, A.
    Balague, C.
    Petriz, L.
    Momblan, D.
    Bellmunt, J.
    Maurel, J.
    ANNALS OF ONCOLOGY, 2012, 23 (03) : 664 - +
  • [25] Induction therapy for locally advanced esophageal or gastric cancer: A phase I/II trial of paclitaxel, carboplatinum, 5-FU and radiation therapy followed by surgery.
    Whiton, MA
    Anne, PR
    Curran, WJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S131 - S132
  • [26] A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC)
    Morita, Satoshi
    Baba, Hideo
    Tsuburaya, Akira
    Takiuchi, Hiroya
    Matsui, Takanori
    Maehara, Yoshihiko
    Sakamoto, Junichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (06) : 469 - 472
  • [27] Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer.
    Enzinger, PC
    Clark, J
    Ryan, D
    Meyerhardt, J
    Kulke, M
    Fidias, P
    Earle, C
    Vincitore, M
    Michelini, A
    Fuchs, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 323S - 323S
  • [28] A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer
    Philip, PA
    Zalupski, MM
    Gadgeel, S
    Hussain, M
    Shields, A
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S86 - S88
  • [29] ETOPOSIDE, DOXORUBICIN, AND CISPLATIN CHEMOTHERAPY FOR ADVANCED GASTRIC ADENOCARCINOMA - RESULTS OF A PHASE-II TRIAL
    LERNER, A
    GONIN, R
    STEELE, GD
    MAYER, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 536 - 540
  • [30] Oxaliplatin, irinotecan, and 5-fluorouracil/leucovorin in advanced gastric adenocarcinoma: A phase II trial
    Comella, P.
    Lorusso, V.
    Maiorino, L.
    Casaretti, R.
    Cannone, M.
    Massidda, B.
    Farris, A.
    Leo, S.
    Roselli, M.
    Sandomenico, C.
    Mancarella, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345